Cargando…
Recombinant Human HAPLN1 Mitigates Pulmonary Emphysema by Increasing TGF-β Receptor I and Sirtuins Levels in Human Alveolar Epithelial Cells
Chronic obstructive pulmonary disease (COPD) will be the third leading cause of death worldwide by 2030. One of its components, emphysema, has been defined as a lung disease that irreversibly damages the lungs’ alveoli. Treatment is currently unavailable for emphysema symptoms and complete cure of t...
Autores principales: | Piao, Yongwei, Yun, So Yoon, Fu, Zhicheng, Jang, Ji Min, Back, Moon Jung, Kim, Ha Hyung, Kim, Dae Kyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495690/ https://www.ncbi.nlm.nih.gov/pubmed/37587649 http://dx.doi.org/10.14348/molcells.2023.0097 |
Ejemplares similares
-
Novel Effect of Hyaluronan and Proteoglycan Link Protein 1 (HAPLN1) on Hair Follicle Cells Proliferation and Hair Growth
por: Ha, Hae Chan, et al.
Publicado: (2023) -
A Novel Role of Hyaluronic Acid and Proteoglycan Link Protein 1 (HAPLN1) in Delaying Vascular Endothelial Cell Senescence
por: Zhou, Dan, et al.
Publicado: (2023) -
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
por: Wiedmann, Lena, et al.
Publicado: (2023) -
Hapln2 in Neurological Diseases and Its Potential as Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2019) -
Mitochondrial dysfunction in human primary alveolar type II cells in emphysema
por: Kosmider, Beata, et al.
Publicado: (2019)